| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2016 | Jul 20, 2016 | ARDELYX, INC. | 10% Owner | Buy | 100.0 | +2,290,951 | 19.43% | ✗ | $20M |
| Jan 13, 2016 | Jan 14, 2016 | ARDELYX, INC. | 10% Owner | Buy | 100.0 | +1,500,000 | 14.57% | ✗ | $15M |
| Oct 5, 2015 | Oct 6, 2015 | SYNLOGIC, INC. | 10% Owner | Buy | 100.0 | +1,146,308 | 21.08% | ✗ | $6M |
| Jun 5, 2015 | Jun 9, 2015 | ARDELYX, INC. | 10% Owner | Buy | 100.0 | +4,672,897 | 83.15% | ✗ | $50M |
| Dec 23, 2014 | Dec 29, 2014 | ARDELYX, INC. | 10% Owner | Sell | 52.5 | -10,000 | -0.18% | ✗ | $5.4K |
| Aug 27, 2014 | Aug 29, 2014 | Viracta Therapeutics, Inc. | 10% Owner | Sell | 17.5 | -266,700 | -5.41% | ✗ | $2.1M |
| Aug 8, 2014 | Aug 12, 2014 | Viracta Therapeutics, Inc. | 10% Owner | Sell | 17.5 | -710,540 | -12.61% | ✗ | $4.7M |
| Jan 15, 2014 | Jan 15, 2014 | CRESCENT BIOPHARMA, INC. | 10% Owner | Buy | 100.0 | +512,500 | 14.31% | ✗ | $4.1M |
| Jun 30, 2010 | Jul 2, 2010 | Viracta Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +23,824,451 | 100.00% | ✗ | $6.6M |